AstraZeneca PLC (AZN) — Strategic Asset Allocation Index
AstraZeneca PLC (AZN) has a Strategic Asset Allocation Index of 30.2% as of December 2025. Strategic assets (PP&E of $14.70 Billion plus long-term investments of $-) total $14.70 Billion, measured against net assets of $48.72 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
AstraZeneca PLC Strategic Asset Allocation Index (2022–2025)
This chart shows how AstraZeneca PLC's Strategic Asset Allocation Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 30.2%, representing strategic assets of $14.70 Billion against net assets of $48.72 Billion USD. Explore AstraZeneca PLC cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for AstraZeneca PLC (2022–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for AstraZeneca PLC from 2022 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of AstraZeneca PLC.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 30.2% | $14.70 Billion | $14.70 Billion | $- | $48.72 Billion | ▲ +1.7 pp |
| 2024 | 28.5% | $11.65 Billion | $11.65 Billion | $- | $40.87 Billion | ▲ +1.7 pp |
| 2023 | 26.8% | $10.50 Billion | $10.50 Billion | $- | $39.17 Billion | ▲ +1.3 pp |
| 2022 | 25.5% | $9.45 Billion | $9.45 Billion | $- | $37.06 Billion | — |